Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for Beauty Health (SKIN) over the last 6 years, with Dec 2024 value amounting to $9.9 million.

  • Beauty Health's Depreciation & Amortization (CF) fell 79.15% to $637,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 63.67%. This contributed to the annual value of $9.9 million for FY2024, which is 12.28% down from last year.
  • Per Beauty Health's latest filing, its Depreciation & Amortization (CF) stood at $9.9 million for FY2024, which was down 12.28% from $11.3 million recorded in FY2023.
  • Beauty Health's Depreciation & Amortization (CF)'s 5-year high stood at $11.3 million during FY2023, with a 5-year trough of $2.6 million in FY2020.
  • Its 3-year average for Depreciation & Amortization (CF) is $9.5 million, with a median of $9.9 million in 2024.
  • As far as peak fluctuations go, Beauty Health's Depreciation & Amortization (CF) surged by 85.60% in 2020, and later dropped by 12.28% in 2024.
  • Over the past 5 years, Beauty Health's Depreciation & Amortization (CF) (Yearly) stood at $2.6 million in 2020, then skyrocketed by 75.78% to $4.5 million in 2021, then skyrocketed by 59.70% to $7.2 million in 2022, then skyrocketed by 58.18% to $11.3 million in 2023, then declined by 12.28% to $9.9 million in 2024.